These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18549440)

  • 21. Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview.
    Kakoullis L; Papachristodoulou E; Chra P; Panos G
    J Infect; 2019 Aug; 79(2):75-94. PubMed ID: 31150744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
    Jenssen GR; Vold L; Hovland E; Bangstad HJ; Nygård K; Bjerre A
    BMC Infect Dis; 2016 Jun; 16():285. PubMed ID: 27297224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral administration of Shiga toxin-producing Escherichia coli induces intestinal and systemic specific immune response in mice.
    Fernandez-Brando RJ; Cabrera G; Baschkier A; Mejías MP; Panek CA; Miliwebsky E; Abrey-Recalde MJ; Bentancor LV; Ramos MV; Rivas M; Palermo MS
    Med Microbiol Immunol; 2014 Jun; 203(3):145-54. PubMed ID: 24399245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virulence factors of Shiga toxin-producing Escherichia coli and the risk of developing haemolytic uraemic syndrome in Norway, 1992-2013.
    Naseer U; Løbersli I; Hindrum M; Bruvik T; Brandal LT
    Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1613-1620. PubMed ID: 28391537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotypes and virulence profiles of Shiga toxin-producing Escherichia coli strains isolated during 2017 from human infections in Switzerland.
    Nüesch-Inderbinen M; Morach M; Cernela N; Althaus D; Jost M; Mäusezahl M; Bloomberg G; Stephan R
    Int J Med Microbiol; 2018 Oct; 308(7):933-939. PubMed ID: 30042042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative genomic analysis of a Shiga toxin-producing Escherichia coli (STEC) O145:H25 associated with a severe pediatric case of hemolytic uremic syndrome in Davidson County, Tennessee, US.
    Guerra JA; Zhang C; Bard JE; Yergeau D; Halasa N; Gómez-Duarte OG
    BMC Genomics; 2020 Aug; 21(1):564. PubMed ID: 32807093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotypic characterization of Escherichia coli O157:H7 strains that cause diarrhea and hemolytic uremic syndrome in Neuquén, Argentina.
    Pianciola L; Chinen I; Mazzeo M; Miliwebsky E; González G; Müller C; Carbonari C; Navello M; Zitta E; Rivas M
    Int J Med Microbiol; 2014 May; 304(3-4):499-504. PubMed ID: 24702854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enterohaemorrhagic Escherichia coli in human medicine.
    Karch H; Tarr PI; Bielaszewska M
    Int J Med Microbiol; 2005 Oct; 295(6-7):405-18. PubMed ID: 16238016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.
    Detzner J; Pohlentz G; Müthing J
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32512916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
    Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epidemiology of Shiga toxin-producing Escherichia coli infections in the South East of England: November 2013-March 2017 and significance for clinical and public health.
    Carroll KJ; Harvey-Vince L; Jenkins C; Mohan K; Balasegaram S
    J Med Microbiol; 2019 Jun; 68(6):930-939. PubMed ID: 30994441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome.
    Chaisri U; Nagata M; Kurazono H; Horie H; Tongtawe P; Hayashi H; Watanabe T; Tapchaisri P; Chongsa-nguan M; Chaicumpa W
    Microb Pathog; 2001 Aug; 31(2):59-67. PubMed ID: 11453701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006.
    Hedican EB; Medus C; Besser JM; Juni BA; Koziol B; Taylor C; Smith KE
    Clin Infect Dis; 2009 Aug; 49(3):358-64. PubMed ID: 19548834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice.
    Eaton KA; Friedman DI; Francis GJ; Tyler JS; Young VB; Haeger J; Abu-Ali G; Whittam TS
    Infect Immun; 2008 Jul; 76(7):3054-63. PubMed ID: 18443087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of Colitis in Germ-Free Mice Infected With EHEC O157:H7.
    Eaton KA; Fontaine C; Friedman DI; Conti N; Alteri CJ
    Vet Pathol; 2017 Jul; 54(4):710-719. PubMed ID: 28178427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between Shiga Toxin-Producing Escherichia coli O157:H7 stx Gene Subtype and Disease Severity, England, 2009-2019.
    Byrne L; Adams N; Jenkins C
    Emerg Infect Dis; 2020 Oct; 26(10):2394-2400. PubMed ID: 32946720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Biology of
    Menge C
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32456125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New knowledge of the molecular biology of enterohemorrhagic Escherichia coli (EHEC) O157].
    Karch H; Köhler B
    Gesundheitswesen; 1999 Oct; 61 Spec No 1():S46-51. PubMed ID: 10593045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7.
    Martorelli L; Garimano N; Fiorentino GA; Vilte DA; Garbaccio SG; Barth SA; Menge C; Ibarra C; Palermo MS; Cataldi A
    Vaccine; 2018 Jun; 36(27):3949-3959. PubMed ID: 29807709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between pathogenicity for humans and stx genotype in Shiga toxin-producing Escherichia coli serotype O157.
    Kawano K; Okada M; Haga T; Maeda K; Goto Y
    Eur J Clin Microbiol Infect Dis; 2008 Mar; 27(3):227-32. PubMed ID: 18071766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.